Research & Literature

Esophageal Involvement in Multiple System Atrophy.

Taniguchi H, Nakayama H, Hori K, et al.

Dysphagia 2015; (30(6)):669-73 doi:10.1007/s00455-015-9641-2.

A consensus review on the development of palliative care for patients with chronic and progressive neurological disease.

Oliver DJ, Borasio GD, Caraceni A, et al.

European journal of neurology 2016; (23(1)):30-8 doi:10.1111/ene.12889.

Survival in synucleinopathies: A prospective cohort study.

Goldstein DS, Holmes C, Sharabi Y, Wu T

Neurology 2015; (85(18)):1554-61 doi:10.1212/WNL.0000000000002086.

Droxidopa for orthostatic hypotension: a systematic review and meta-analysis.

Strassheim V, Newton JL, Tan MP, Frith J

Journal of hypertension 2016; (34(10)):1933-41 doi:10.1097/HJH.0000000000001043.

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

Espay AJ, LeWitt PA, Hauser RA, et al.

The Lancet. Neurology 2016; (15(9)):954-966 doi:10.1016/S1474-4422(16)30079-5.

Integration of Early Specialist Palliative Care in Cancer Care and Patient Related Outcomes: A Critical Review of Evidence.

Salins N, Ramanjulu R, Patra L, et al.

Indian journal of palliative care 2016; (22(3)):252-7 doi:10.4103/0973-1075.185028.

Palliative Care Discussions in Multiple System Atrophy: A Retrospective Review.

Dayal AM, Jenkins ME, Jog MS, et al.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2017; (44(3)):276-282 doi:10.1017/cjn.2016.439.

Early palliative care for adults with advanced cancer.

Haun MW, Estel S, Rücker G, et al.

The Cochrane database of systematic reviews 2017; (6()):CD011129 doi:10.1002/14651858.CD011129.pub2.

Symptomatic therapy of multiple system atrophy.

Rohrer G, Höglinger GU, Levin J

Autonomic neuroscience : basic & clinical 2018; (211()):26-30 doi:10.1016/j.autneu.2017.10.006.

Therapeutic Management of the Overlapping Syndromes of Atypical Parkinsonism.

Giagkou N, Stamelou M

CNS drugs 2018; (32(9)):827-837 doi:10.1007/s40263-018-0551-3.

Sleep-Disordered Breathing in Multiple System Atrophy: Pathophysiology and New Insights for Diagnosis and Treatment.

Silvestri R

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2018; (14(10)):1641-1642 doi:10.5664/jcsm.7360.

Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.

Miki Y, Foti SC, Asi YT, et al.

Brain : a journal of neurology 2019; (142(9)):2813-2827 doi:10.1093/brain/awz189.

Epigallocatechin gallate in multiple system atrophy (PROMESA).

Jellinger KA

Annals of translational medicine 2019; (7(Suppl 8)):S278 doi:10.21037/atm.2019.11.141.

Is There a Difference in Autonomic Dysfunction Between Multiple System Atrophy Subtypes?

Garg D, Srivastava AK, Jaryal AK, et al.

Movement disorders clinical practice 2020; (7(4)):405-412 doi:10.1002/mdc3.12936.

Parkinsonian and Cerebellar Phenotypes of Probable MSA: An Insight in to Prognostic Factors Based on Autonomic Functions.

Rukmani MR, Yadav R, Bhaskarapillai B, et al.

Annals of Indian Academy of Neurology 2020; (23(3)):289-295 doi:10.4103/aian.AIAN_34_19.

Signs of early cellular dysfunction in multiple system atrophy.

Herrera-Vaquero M, Heras-Garvin A, Krismer F, et al.

Neuropathology and applied neurobiology 2021; (47(2)):268-282 doi:10.1111/nan.12661.

Respiratory and sleep-related complications of multiple system atrophy.

Ralls F, Cutchen L

Current opinion in pulmonary medicine 2020; (26(6)):615-622 doi:10.1097/MCP.0000000000000725.

Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group.

Pellecchia MT, Stankovic I, Fanciulli A, et al.

Movement disorders clinical practice 2020; (7(7)):750-762 doi:10.1002/mdc3.13052.

A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.

Simões RM, Castro Caldas A, Grilo J, et al.

BMC neurology 2020; (20(1)):432 doi:10.1186/s12883-020-02007-5.

Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.

Hewitt LA, Lindsten A, Gorny S, et al.

Health science reports 2021; (4(1)):e227 doi:10.1002/hsr2.227.

Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.

Isaacson SH, Dashtipour K, Mehdirad AA, Peltier AC

Current neurology and neuroscience reports 2021; (21(4)):18 doi:10.1007/s11910-021-01104-3.

Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.

Rascol O, Cochen de Cock V, Pavy-Le Traon A, et al.

Movement disorders : official journal of the Movement Disorder Society 2021; (36(7)):1704-1711 doi:10.1002/mds.28569.

A historical review of multiple system atrophy with a critical appraisal of cellular and animal models.

Marmion DJ, Peelaerts W, Kordower JH

Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(10)):1507-1527 doi:10.1007/s00702-021-02419-8.

Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study.

Eschlböck S, Kiss G, Krismer F, et al.

Movement disorders clinical practice 2021; (8(7)):1052-1060 doi:10.1002/mdc3.13307.

Endoscopic Characteristics of Dysphagia in Multiple System Atrophy Compared to Parkinson's Disease.

Vogel A, Claus I, Ahring S, et al.

Movement disorders : official journal of the Movement Disorder Society 2022; (37(3)):535-544 doi:10.1002/mds.28854.

Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Provitera V, Iodice V, Manganelli F, et al.

Neurology 2022; (98(12)):e1282-e1291 doi:10.1212/WNL.0000000000013300.

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.

Teil M, Dovero S, Bourdenx M, et al.

Brain : a journal of neurology 2022; (145(3)):1001-1017 doi:10.1093/brain/awab374.

Parkinson's disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein-induced changes in maturation and immune reactive properties.

Azevedo C, Teku G, Pomeshchik Y, et al.

Proceedings of the National Academy of Sciences of the United States of America 2022; (119(12)):e2111405119 doi:10.1073/pnas.2111405119.

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.

Wenning GK, Stankovic I, Vignatelli L, et al.

Movement disorders : official journal of the Movement Disorder Society 2022; (37(6)):1131-1148 doi:10.1002/mds.29005.

Disease Mechanisms of Multiple System Atrophy: What a Parallel Between the Form of Pasta and the Alpha-Synuclein Assemblies Involved in MSA and PD Tells Us.

Melki R

Cerebellum (London, England) 2024; (23(1)):13-21 doi:10.1007/s12311-022-01417-0.

Chemical disaggregation of alpha-synuclein fibrils as a therapy for synucleinopathies.

Wu S, Hernandez Villegas NC, Schekman R

Proceedings of the National Academy of Sciences of the United States of America 2023; (120(11)):e2300965120 doi:10.1073/pnas.2300965120.

Multiple system atrophy.

Goh YY, Saunders E, Pavey S, et al.

Practical neurology 2023; (23(3)):208-221 doi:10.1136/pn-2020-002797.

An Update on Parkinson's Disease and its Neurodegenerative Counterparts.

Adam H, Gopinath SCB, Arshad MKM, et al.

Current medicinal chemistry 2024; (31(19)):2770-2787 doi:10.2174/0929867330666230403085733.

Sentence completion in progressive supranuclear palsy following transcranial direct current stimulation.

Scholtz J, Weiss S, Redecker C, Müller HM

NPJ Parkinson's disease 2023; (9(1)):162 doi:10.1038/s41531-023-00610-0.

Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association.

Juraschek SP, Cortez MM, Flack JM, et al.

Hypertension (Dallas, Tex. : 1979) 2024; (81(3)):e16-e30 doi:10.1161/HYP.0000000000000236.

Palliative Care Aspects in Multiple Sclerosis.

Mercadante S

Journal of pain and symptom management 2024; (67(5)):e425-e437 doi:10.1016/j.jpainsymman.2024.01.006.

Differentiation between Parkinson's Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle.

Wang J, Sugiyama A, Yokota H, et al.

Diagnostics (Basel, Switzerland) 2024; (14(2)) doi:10.3390/diagnostics14020201.

Current practice of hospital-based palliative care teams: Advance care planning in advanced stages of disease: A retrospective observational study.

van Doorne I, Willems DL, Baks N, et al.

PloS one 2024; (19(2)):e0288514 doi:10.1371/journal.pone.0288514.

Nature of Parkinsonian features in multiple system atrophy.

Pradhan S, Tandon R

Journal of neurosciences in rural practice 2024; (15(2)):211-216 doi:10.25259/JNRP_445_2023.

SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.

Kon T, Forrest SL, Lee S, et al.

Neurobiology of disease 2024; (198()):106551 doi:10.1016/j.nbd.2024.106551.

Early-onset dysphagia predicts short survival in multiple system atrophy.

Wada T, Shimizu T, Asano Y, et al.

Journal of neurology 2024; (271(10)):6715-6723 doi:10.1007/s00415-024-12623-7.

A strategic approach of the management of sleep-disordered breathing in multiple system atrophy.

Laga A, Bauters F, Hertegonne K, et al.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025; (21(4)):703-711 doi:10.5664/jcsm.11472.

Multiple system atrophy related neurogenic bladder: mechanism and treatment.

Ren G, Wang Y, Tian H, et al.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(5)):1965-1976 doi:10.1007/s10072-025-08002-3.

Ankle plantar-dorsal flexion exercises mitigate orthostatic hypotension in patients with neurodegenerative diseases.

Akiba T, Terayama K, Ogawa A, et al.

International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation 2025; (48(3)):157-165 doi:10.1097/MRR.0000000000000671.

Levodopa-carbidopa intestinal gel for multiple system atrophy with motor fluctuations: a case series.

Iseki T, Nishikawa N, Ogawa T, et al.

Therapeutic advances in neurological disorders 2025; (18()):17562864251360048 doi:10.1177/17562864251360048.

Cerebral Astrocytic Phosphorylated-α-Synuclein Accumulation in Multiple System Atrophy With Long Clinical Course.

Sakai K

Neuropathology : official journal of the Japanese Society of Neuropathology 2025; (45(5)):e70026 doi:10.1111/neup.70026.